Also trades as: 0HWG.L (LSE) · $vol 0M
CC NYSE
The Chemours Company
1W: -13.4%
1M: -10.8%
3M: +26.6%
YTD: +76.0%
1Y: +94.7%
3Y: -15.0%
5Y: -25.3%
$21.37
-0.07 (-0.33%)
Weekly Expected Move ±12.1%
$18
$20
$23
$26
$29
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (59)
$CC - The next bottle neck?
Twilio To Rally Over 25%? Here Are 10 Top Analyst Forecasts For Monday
Why Silver, Power And Chemicals Will Be The Next Micron Trade, Top AI Expert Says
Chemours' Q1 Earnings Surpass Estimates, Revenues Miss
Chemours expects Q2 adjusted EBITDA of $220M-$250M as it targets net leverage below 3.8x by year-end 2026
Chemours (CC) Q1 2026 Earnings Transcript
Chemours declines 13% after mixed quarter, flags higher financing costs
You Just Missed The SanDisk And Micron Memory Trade: These 10 Stocks Could Ride The Next AI Wave
Full Transcript: Chemours Q1 2026 Earnings Call
Chemours declares $0.0875 dividend
Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say
Alta Fundamental Dumps 175K Chemours Shares in Q1
Here are the major earnings after the close Tuesday
Earnings Scheduled For May 5, 2026
IAMGOLD to Report Q1 Earnings: What's in Store for the Stock?
Ero Copper Gears Up to Report Q1 Earnings: Here's What to Expect
Should You Buy OEC Stock at 19.84x P/E Amid a FY26 Earnings Reset?
OEC's Specialty Pricing: What the 2026 Surcharge Signals
OEC Faces Earnings Reset in 2026: What Investors Should Watch
26,682 Shares in The Chemours Company $CC Acquired by Argyle Capital Management LLC
Dow, LyondellBasell top S&P 500 losers as oil's plunge pressures chemical industry pricing, margins
Iran conflict sparks sudden boom for U.S. chemical makers
SG Americas Securities LLC Purchases 195,393 Shares of The Chemours Company $CC
Oxford Biomedica plc reports FY results
Hudson Bay Capital Management LP Buys New Holdings in The Chemours Company $CC
Iran War Ripples Across Global Commodities, BMO Warns
Dynamic Technology Lab Private Ltd Invests $444,000 in The Chemours Company $CC
American Century Companies Inc. Purchases 490,988 Shares of The Chemours Company $CC
Citigroup Inc. Lowers Position in The Chemours Company $CC
Chemours Upsizes and Prices $700 Million Senior Notes Offering
Chemours prices upsized $700M 7.875% senior notes due 2034
The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
The Chemours Company launches $600M private offering
The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2034
Alcon Non-GAAP EPS of $0.78 misses by $0.01, revenue of $2.7B misses by $10M
Following Successful Fluid Qualification Chemours & 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers & IT Equipment
Chemours: No Rush To Buy The Dip Given Non-AI Pressures (Downgrade)
Chemours' Gerardo Familiar Appointed to SEMI North America Advisory Board
Chemours' Q4 Earnings Surpass Estimates, Revenues In Line
Chemours outlines $800M–$900M adjusted EBITDA target for 2026 with focus on cash flow and deleveraging
Why Chemours Plunged Today
Chemours slides 11% on Q4 weakness in advanced performance materials
The Chemours Company (CC) Q4 2025 Earnings Call Transcript
Chemours Stock Tumbles After Earnings. Data-Center Cooling Couldn't Save the Quarter.
Investors Buy High Volume of Call Options on Chemours (NYSE:CC)
Chemours Announces First Quarter Dividend
Curious about Chemours (CC) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE:CC) Receives Average Rating of “Hold” from Brokerages
Chemours: Upside More Confirmed In 2026E
CC to Sell Former Titanium Dioxide Taiwan Site Land for $360M
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan
Hagens Berman: Montana Court Denies Motions to Dismiss Class-Action Lawsuit Fighting PFAS in Firefighter Turnout Gear
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
Reviewing Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Chemours (NYSE:CC)
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs